Markets
-
European Equities: The European session is marked by deep declines. The largest outflows are seen in emerging markets (Poland's W20: -1.6%), though the broader European market is losing only slightly less (EU50: -1.3%). The sell-off is broad-based, hitting growth (Tech: ASML -3.4%), cyclical (Finance: HSBC -0.7%), and defensive sectors (Pharmaceuticals: Roche -2.8%, GSK -1.3%). The only "green island" today is the energy sector (Shell +1.4%, BP +2.0%).
-
Corporate News: An experimental obesity drug from Roche and Zealand Pharma disappointed investors, delivering only a 10.7% weight loss after 42 weeks. Consequently, Zealand shares plummeted by a record 32%, and Roche fell by 3.3%. Despite minimal side effects, analysts doubt the compound will become a first-choice treatment in this highly competitive market.
-
Currencies: The US Dollar Index is adding another 0.3% and currently sits at its highest level since December 2025. The euro is taking the biggest hit (EUR/USD: -0.4% to 1.156), while other safe havens are also in retreat: the Swiss franc (USD/CHF: +0.15%) and the Japanese yen (USD/JPY: +0.3%).
-
Commodities: Gold is extending yesterday's correction by an additional 0.2% to $5,070, weighed down by further gains in the dollar. Brent crude is jumping another 5.7% to nearly $89, while WTI is surging by 8.7% to nearly $86 per barrel.
Economy and Politics
-
Eurozone GDP: The latest GDP reading for the Eurozone was revised downwards from 1.3% to 1.2% YoY. In the fourth quarter of 2025, GDP growth in the Eurozone and the EU was driven by positive contributions from household consumption, government expenditure, and fixed capital investment. However, overall growth was dragged down by falling exports and a negative contribution from inventories.
-
Fed Commentary: The Fed's Christopher Waller noted that the war in Iran should not lead to a long-term rise in inflation. However, his tone wasn't entirely dovish—Waller warned that an energy price shock stretching over weeks or months will be a problem for the Fed, noting that previous energy shocks have permanently raised price levels.
-
US-Iran Conflict: In recent interviews, President Trump stated that Americans should anticipate the risk of Iranian attacks, noting that during war, "people die." He also announced that the goal of the military operation is complete regime change in Iran and the installation, with US support, of a new, "reasonable" leader, for which he already has specific candidates in mind.
-
EU Response: Ursula von der Leyen and Antonio Costa will meet with Gulf country leaders on Monday to discuss the Middle East conflict. The EU is concerned about war escalation, as well as potential energy and migration crises. Due to these threats, EU meetings in Cyprus have been canceled, while aid to the region is being increased.
-
Energy Security: According to the German Minister for Economic Affairs, "[energy commodity] markets remain liquid, and there are no problem about the security of gas supplies." However, the shutdown of LNG production in Qatar was a primary driver of the euro's decline, given the region's high economic sensitivity to commodity prices.

EU50 is at its lowest since December 2025, while EURUSD deepens losses below 1,1600 mark. Source: xStation5
Daily summary: Indices and crypto decline amid rising oil prices 🚩 Gold and the US dollar move higher
Oil surges 11% amid escalating Middle-East conflict 📈VIX gains driven by fear on Wall Street
BREAKING: Iran signals Europe will be 'a legitimate target' if EU joins war
Bitcoin loses the momentum again 📉Ethereum slides 5%
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.